DOC Stock Analysis — Healthpeak Properties
Sector: Healthcare REIT
AI Verdict
DOC trades at 92.5x next year's earnings while earnings are expected to shrink by over a third, so even with a defensible property base, you're paying a premium the numbers don't yet support.
Competitive Moat
Healthpeak owns and operates a diversified portfolio of medical office buildings and life science properties, which are typically leased to creditworthy healthcare tenants on long-term contracts. The moat comes from high switching costs for tenants and the specialized build-outs required for medical and lab spaces, making these properties less vulnerable to generic competition.
Summary
DOC's RSI of 20.2 signals extreme oversold territory after a sharp sentiment shift.
Where It Stands
Healthpeak is up 18.6% over the past year but trades at 92.5x next year's earnings with -36.5% forward EPS growth expected, while its RSI of 20.2 suggests shares are deeply oversold.
Key Metrics
- RSI: 20.2 — Oversold
- Trailing P/E: 58.7x
- Forward P/E: 92.5x
- Earnings Growth: -0.4%
- Revenue Growth: +0.1%
- Market Cap: $14.2B
- Dividend Yield: 0.06%
- 1-Year Return: 18.60%
- 52-Week High: $22.95
- 52-Week Low: $15.70
Analyst Consensus
10 Buy · 16 Hold · 0 Sell (26 analysts)
Bull Case
The 18.6% one-year return and sector-specific property moat could attract value hunters as the RSI hits 20.2, a rare oversold reading.
Bear Case
A forward P/E of 92.5x with -36.5% expected EPS growth means any normalization to the healthcare REIT median P/E of 22x would imply a 76% valuation drop.
Catalyst to Watch
Watch for earnings guidance updates—any sign of stabilizing or reversing the -36.5% EPS decline could trigger a sharp rebound from oversold levels.